(Q44619032)

4 December 2017

title

Febrile lady with acute renal failure and desquamating erythema (English)

1 reference

4 December 2017

Roth S

1

1 reference

4 December 2017

Andrassy K

2

1 reference

4 December 2017

Schmidt KH

3

1 reference

4 December 2017

Günther E

4

1 reference

4 December 2017

Ritz E

5

1 reference

4 December 2017

publication date

1 July 1999

1 reference

American Journal of Kidney Diseases

4 December 2017

published in

1 reference

4 December 2017

volume

34

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

150-154

1 reference

A secreted receptor related to M1 protein of Streptococcus pyogenes binds to fibrinogen, IgG, and albumin

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Endophthalmitis as presenting symptom of group G streptococcal endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Group G streptococcal endocarditis and bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Toxic-shock syndrome associated with phage-group-I Staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

V beta-specific stimulation of human T cells by staphylococcal toxins.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Separation of T-cell-stimulating activity from streptococcal M protein

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

Streptococcus pyogenes type 5 M protein is an antigen, not a superantigen, for human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970122-8

7 January 2021

10.1016/S0272-6386(99)70122-8

Identifiers

DOI

1 reference

4 December 2017

1 reference